[Myocardial revascularization before abdominal aortic surgery in patients with ischemic heart disease]

Kardiologiia
|August 20, 2013
PubMed

Insights

Routine coronary angiography and preventive myocardial revascularization before abdominal aortic surgery significantly reduced perioperative complications and mortality. This strategy lowered cardiac events and hospital deaths compared to standard medical therapy alone.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Anesthesiology

Background:

  • Perioperative cardiac risk management is crucial for patients undergoing major vascular surgery.
  • Different preoperative strategies exist for assessing and mitigating cardiac risk.
  • Abdominal aortic surgery carries a significant risk of cardiac complications.

Purpose of the Study:

  • To compare the effectiveness of two distinct preoperative cardiac risk management strategies in patients undergoing abdominal aortic surgery.
  • To evaluate the impact of routine coronary angiography and preventive myocardial revascularization on perioperative outcomes.

Main Methods:

  • Retrospective analysis of two patient cohorts (n=86 in group I, n=95 in group II).
  • Group I: underwent coronary angiography (CAG) and preventive myocardial revascularization if indicated.
  • Group II: received only medical therapy for cardiac risk management.

Main Results:

  • Group I demonstrated significantly lower total complications (8% vs. 20%, p=0.023) and hospital mortality (2.3% vs. 10.5%, p=0.026) compared to Group II.
  • CAG was performed in 90% of Group I patients, with myocardial revascularization in 28%.
  • No cardiac complications or deaths occurred in Group I, whereas Group II experienced 6 deaths (6.3%) due to myocardial infarction.

Conclusions:

  • Routine coronary angiography and preventive myocardial revascularization before abdominal aortic surgery are associated with improved patient outcomes.
  • This proactive cardiac risk reduction strategy significantly decreases perioperative complications, myocardial infarctions, and mortality.
  • The findings support the integration of comprehensive cardiac assessment and intervention in high-risk surgical patients.

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...